North America Patient Registry Software Market (2025-2030)
The North America Patient Registry Software Market was valued at $1092.3 Million in 2025 and projected to reach to $1744.6 Million by 2030, representing a compound annual growth rate of 9.8%. North America dominates the global patient registry software market, driven by advanced healthcare infrastructure, stringent regulatory requirements, and widespread EHR adoption.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Patient Registry Software Market Trends and Insights
- North America's advanced healthcare infrastructure, regulatory compliance requirements, and increasing adoption of electronic health records are driving demand for sophisticated registry solutions.
- In 2025, North America represents a mature yet expanding market where healthcare organizations prioritize data interoperability and patient outcomes tracking. By 2030, North America is expected to see accelerated adoption driven by value-based care models and precision medicine initiatives.
- North America's emphasis on regulatory compliance, particularly through HIPAA and state-level mandates, continues to fuel investment in secure, scalable registry platforms.
- The region's strong healthcare IT spending and focus on chronic disease management position North America as a critical growth market for patient registry software vendors..
Key Market Statistics
- CAGR (2025-2030) 9.8% CAGR
- Market Size, 2025 ~USD 1092.3 Million
- Forecast, 2030 ~USD 1744.6 Million
- Geography North America
North America Patient Registry Software Market Overview
Market Valuation & Growth :
North America's patient registry software market is valued at $1,092.3 million in 2025, with a projected CAGR of 9.8% through 2030, reaching $1,744.6 million. This robust growth reflects strong healthcare digitalization trends across the region.
Regulatory Compliance Drivers :
Stringent healthcare regulations including HIPAA, FDA requirements, and state-level compliance mandates are compelling North American healthcare organizations to invest in advanced patient registry solutions for data security and reporting.
EHR Integration Adoption :
The widespread adoption of electronic health records across North American healthcare systems is accelerating demand for interoperable patient registry software that seamlessly integrates with existing clinical infrastructure.
Advanced Healthcare Infrastructure :
North America's mature healthcare ecosystem, characterized by high technology adoption rates and significant IT budgets, positions the region as a leader in sophisticated registry solution implementation and innovation.
North America Patient Registry Software Market Dynamics
- The region's healthcare organizations are increasingly prioritizing data-driven decision-making and patient outcomes tracking, fueling demand for sophisticated registry platforms.
- Healthcare providers are investing heavily in compliance solutions to meet HIPAA and FDA standards while improving operational efficiency. The forecast period through 2030 shows sustained growth momentum as North American healthcare systems modernize legacy systems and expand registry capabilities.
- Consolidation among healthcare providers, rising chronic disease prevalence, and growing emphasis on precision medicine are expected to drive continued market expansion.
- Investment in cloud-based registry solutions and AI-powered analytics will further accelerate adoption across hospitals, specialty clinics, and research institutions..
Market Ecosystem
PATIENT REGISTRY SOFTWARE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Healthcare master data management supporting patient identity resolution, deduplication, longitudinal patient records, and integration of patient data across healthcare applications | InfoSphere MDM for Patient supports patient registries and health information exchange environments. | Improves patient data accuracy and consistency, reduces duplicate records, strengthens patient identity management, and supports interoperability and reliable registry data management. |
 |
Patient registry solutions supporting disease-specific, product, safety, and quality-improvement registries | The Clinical Insight Registry Platform collects research-ready real-world data from clinicians and patients across multiple sites and geographies. | Streamlines longitudinal patient data collection, supports patient-reported and clinician-reported data, enables clinical research and real-world evidence generation, and facilitates quality improvement and patient outcome analysis. |
 |
ARMUS clinical registry software supporting registry development, data abstraction, validation, management, submission, and analytics for hospitals, healthcare systems, and medical societies. | Reduces manual data abstraction effort, improves data quality and registry submission efficiency, supports standardized reporting and benchmarking, and enables analysis of clinical outcomes across providers and facilities. |
 |
Healthcare applications supporting patient registration and data management, alongside public-health capabilities such as immunization registry reporting and immunization management. | Streamlines patient registration and healthcare workflows, supports public-health reporting and immunization data management, and facilitates access to consistent patient information across clinical and administrative processes. |
 |
Healthcare data and analytics solutions supporting patient registries, patient cohort identification, longitudinal data management, and population health analysis through integration of electronic medical records and other healthcare data sources. | Supports patient identification and stratification, enables longitudinal monitoring and outcomes analysis, improves population health management, and helps healthcare organizations use clinical and administrative data for informed care decisions. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Key Takeaways
- North America patient registry software market grows from $1,092.3M (2025) to $1,744.6M (2030) at 9.8% CAGR
- North America's regulatory environment and value-based care adoption drive sustained demand for registry solutions
- North America healthcare organizations prioritize interoperability and real-world evidence collection capabilities
- North America represents the largest regional market with mature IT infrastructure supporting advanced registry deployments
Patient Registry Software Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CLOUD-BASED MODELS (Deployment) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 9.9% from 2025 to 2030 |
| Largest Segment | DISEASE REGISTRIES (Registry Type) |
| Market Size Base Year (Billions) | ~USD 2.25 (2025) |
| Revenue Forecast (Billions) | ~USD 3.61 (2030) |
| Segments Covered | Registry Type, Type, Product, Use Case, Deployment, End User |
North America Patient Registry Software Market Report Segmentation
6 segment dimensions are covered across the global market.
By Registry Type
- Disease Registries
- Product Registries
By Type
- Asthma Registries
- Birth Defect Registries
- Cancer Registries
- Cardiovascular Registries
- Chronic Kidney Registries
- Clinics & Outpatient Settings
- Diabetes Registries
- Drug Registries
- Healthcare Payers
- Healthcare Providers
- Hospitals
- Immunization Registries
- Medical Device Registries
- Medical Specialty Societies
- Orthopedic Registries
- Other Disease Registries
- Other Healthcare Providers
- Patient Organizations
- Pharmaceutical, Biotechnology, And Medtech Companies
- Rare Disease Registries
By Product
- Direct-To-Patient (Patient-Recorded) Registries
- Site-Based/Clinical Data (Provider-Recorded) Registries
By Use Case
- Medical Research & Clinical Studies
- Other Use Cases
- Patient Care Management
- Patient Engagement
- Patient Self-Care
- Point-Of-Care Support
- Population Health
- Public Health Surveillance
- Quality Improvement
By Deployment
- Cloud-Based Models
- On-Premise Models
By End User
- For-Profit Registries
- Government & Third-Party Administrators
- Nonprofit Registries
- Other End Users
Target Audience
- Healthcare IT Vendors : Patient registry software providers need North America-specific market data to develop competitive solutions, understand regulatory requirements, and identify growth opportunities in the region's $1.7B+ market.
- Hospital & Health System Executives : C-suite leaders and IT directors require market insights to justify registry software investments, benchmark against peer institutions, and align procurement strategies with regional compliance mandates.
- Healthcare Consultants & Integrators : Implementation partners need detailed North American market analysis to advise clients on registry solution selection, forecast ROI, and understand regional adoption trends and best practices.
- Investment & Private Equity Firms : Investors evaluating healthcare IT opportunities need North America market sizing and growth projections to assess portfolio companies, identify acquisition targets, and evaluate sector valuations.
- Healthcare Researchers & Analysts : Academic institutions and research organizations require granular North American market data to study healthcare digitalization trends, regulatory impacts, and technology adoption patterns in patient data management.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1626.2 Million |
| Canada | USD 118.4 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Quantified market data for North America showing $1,092.3M (2025) to $1,744.6M (2030) with 9.8% CAGR enables accurate forecasting and investment planning specific to the region's healthcare sector.
- Regulatory Compliance Insights : Detailed analysis of HIPAA, FDA, and state-level compliance requirements driving North American adoption helps vendors and providers align solutions with mandatory regulatory frameworks.
- Country-Level Breakdown : Granular market data for US ($1,626.2M) and Canada ($118.4M) allows stakeholders to identify high-opportunity markets and tailor go-to-market strategies by country-specific healthcare dynamics.
- Competitive Positioning : Understanding North America's advanced infrastructure and high technology adoption rates enables vendors to benchmark solutions against regional competitors and identify differentiation opportunities.
- Strategic Investment Decisions : Comprehensive market intelligence supports M&A decisions, product development priorities, and resource allocation for healthcare IT companies targeting the North American patient registry segment.
Frequently asked questions
What is the current size of the North America patient registry software market?
The North America patient registry software market is valued at $1,092.3 million in 2025 and is expected to grow to $1,744.6 million by 2030.
What is the projected growth rate for North America patient registry software?
North America patient registry software market is projected to grow at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2030.
What factors are driving growth in the North America patient registry software market?
Key drivers include regulatory compliance requirements (HIPAA), adoption of value-based care models, increasing EHR integration needs, and focus on chronic disease management and precision medicine.
How does North America compare to other regions in patient registry software adoption?
North America represents a mature, well-established market with advanced healthcare IT infrastructure, strong regulatory frameworks, and higher per-capita spending on healthcare technology solutions compared to other regions.
What are the primary use cases for patient registry software in North America?
Primary use cases include chronic disease management, quality reporting, real-world evidence collection, clinical trial recruitment, and outcomes tracking to support value-based care initiatives.
RESEARCH METHODOLOGY
The study involved several key activities to estimate the current size of the patient registry software market. Extensive secondary research was conducted to gather information on this market. Next, we validated the findings, assumptions, and size estimates through primary research by consulting industry experts across the value chain. We used top-down and bottom-up approaches to estimate the overall market size. Next, we used market segmentation and data triangulation to determine the size of specific segments and subsegments within the patient registry software market.
Secondary Research
This research study relied heavily on secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and companies' SEC filings. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the patient registry software market. It was also used to obtain key information on the key players, market classification & segmentation by industry trends to the most granular level, and key developments from market and technology perspectives. The study also prepared a database of key industry leaders using secondary research.
Some of the key secondary sources referred to for this study include:
- Food and Drug Administration (FDA)
- European Medicines Agency (EMA)
- National Institutes of Health (NIH)
- Agency for Healthcare Research and Quality (AHRQ)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- World Health Organization (WHO)
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
- Health Level Seven International (HL7)
- European Commission (EU)
- International Organization for Standardization (ISO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
- Investor Presentations, SEC Filings, and Company Annual Reports
- White Papers, Scientific Journals/Magazines, and News Articles
- Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources mainly included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of the industry’s value chain. We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to gather and verify critical qualitative and quantitative information and assess prospects.
Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.
Breakdown of primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This study's market size estimates and forecasts are derived from a mix of bottom-up (revenue share analysis of leading players) and top-down approaches (assessment of utilization/adoption/penetration trends by product, use case, registry type, deployment model, end user, and region).
Patient Registry Software Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size, the market was split into several segments and subsegments using market size estimation processes. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by analyzing factors and trends from both the demand and supply sides of the patient registry software market.
Market Definition
Patient registry software is a digital tool that systematically collects, stores, manages, and analyzes patient data on specific diseases, conditions, treatments, or outcomes, enabling real-world evidence generation, research support, and improved clinical decision-making. It facilitates longitudinal tracking of patient outcomes, enhances population health management, and supports regulatory compliance and quality improvement initiatives.
Key Stakeholders
- Patient Registry Software Vendors
- Government Bodies
- Healthcare Providers
- Clinical/Physician Centers
- Healthcare Professionals
- Health IT Service Providers
- Healthcare Associations/Institutes
- Venture Capitalists
- Distributors & Resellers
- Maintenance & Support Service Providers
- Integration Service Providers
- Healthcare Payers
- Advocacy Groups
- Investors & Financial Institutions
- Industry Associations & Trade Groups
Report Objectives
- To define, describe, and forecast the global patient registry software market based on product, use case, registry type, deployment model, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia, Latin America, and the Middle East & Africa
- To profile key market players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches & upgrades; expansions; agreements, partnerships, and acquisitions; and R&D activities in the patient registry software market
Available customizations:
Based on the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe patient registry software market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific patient registry software market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Patient Registry Software Market Report
Full forecast, segment splits, and company analysis for all Patient Registry Software Market.
- Canada Patient Registry Software Market
- US Patient Registry Software Market
- UK Patient Registry Software Market
- Germany Patient Registry Software Market
- France Patient Registry Software Market
- Italy Patient Registry Software Market
- Spain Patient Registry Software Market
- Japan Patient Registry Software Market
- China Patient Registry Software Market
- India Patient Registry Software Market
- Brazil Patient Registry Software Market
- Mexico Patient Registry Software Market
- Rest Of Europe Patient Registry Software Market
- Rest Of Asia Pacific Patient Registry Software Market
- Rest Of Latin America Patient Registry Software Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
